Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Priou

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Thorax|October 28, 2018
Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trialSylvain Recoquillon, Jean-Louis Pépin, Bruno Vielle, et al.
Chest|February 22, 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial AsthmaCendrine Godet, Anne-Laure Brun, Francis Couturaud, et al.
Annals of the American Thoracic Society|February 6, 2020
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-AnalysisBabak Mokhlesi, Juan Fernando Masa, Majid Afshar, et al.
Journal of Autoimmunity|November 2, 2022
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung diseasePierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, et al.
Neurology|June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 casesYves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
The European Respiratory Journal|September 11, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescriptionElise Dreano, Pierre Régis Burgel, Aurelie Hatton, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
The European Respiratory Journal|November 12, 2021
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trialCendrine Godet, Francis Couturaud, Sylvain Marchand-Adam, et al.
The European Respiratory Journal|February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variantPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Thorax|October 28, 2018
Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trialSylvain Recoquillon, Jean-Louis Pépin, Bruno Vielle, et al.
Chest|February 22, 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial AsthmaCendrine Godet, Anne-Laure Brun, Francis Couturaud, et al.
Annals of the American Thoracic Society|February 6, 2020
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-AnalysisBabak Mokhlesi, Juan Fernando Masa, Majid Afshar, et al.
Journal of Autoimmunity|November 2, 2022
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung diseasePierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, et al.
Neurology|June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 casesYves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
The European Respiratory Journal|September 11, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescriptionElise Dreano, Pierre Régis Burgel, Aurelie Hatton, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
The European Respiratory Journal|November 12, 2021
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trialCendrine Godet, Francis Couturaud, Sylvain Marchand-Adam, et al.
The European Respiratory Journal|February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variantPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
Pageof 3